Poster #1: 

Insights of clinical significance from solid tumor profiles with FoundationOne CDx

Poster #2:

Clinical utility of tumor next-generational sequencing (NGS) panel testing to inform treatment decisions for patients with advanced solid tumors

View Poster PDFs